Ticker PHARMListed on Euronext Amsterdam

Pharming Group N.V.

HealthcareLEI 724500DCJ9MPG74JEH91Filings at the AFMNederlands

At a glance

Most recent filing on August 13, 2026 — an open-market purchase by Breidenbach A. on Aug 4, 2026.

Over the past 12 months: 1 open-market purchase and 2 open-market sales.

We hold 242 visible filings, going back to October 13, 2008.

Filings we could not classify with confidence are set aside for review, so they are in none of these counts.

5 of 242 shown

Some of these filings come from the AFM register of board members and supervisory directors (art. 5:48 Wft). The AFM board-member register gives no transaction type; we derive it from the number of shares and the price.

  • Breidenbach A. Chief Business Officer
    €45,500Open-market buy
    TradedAug 4, 2026FiledAug 13, 2026
  • Bernal I. Chief People Officer
    €138,875Open-market sale
    TradedJun 5, 2026FiledJun 10, 2026
  • Sullivan E. Board or supervisory board member
    38,583 sharesOther
    TradedMay 28, 2026FiledMay 28, 2026
  • Pykett M. Board or supervisory board member
    38,583 sharesOther
    TradedMay 28, 2026FiledMay 28, 2026
  • Meijs, van der J. Board or supervisory board member
    38,583 sharesOther
    TradedMay 28, 2026FiledMay 28, 2026

Net short positions of 0.5% or more in Pharming Group N.V. that are open today, as the regulator publishes them. Together they come to 4.85% of the shares. Positions below 0.5% are not published, so the real total can be higher.

6 open positions, together 4.85%. The holders and their history are part of the subscription.

Source: Autoriteit Financiële Markten (AFM), register of net short positions, as published on November 9, 2026.

The insider score is a rank of the most recent scored buy, not a forecast. How it is calculated is in the methodology. Source: the Dutch AFM register (MAR art. 19).